---
document_datetime: 2023-09-21 17:59:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/nutropinaq-epar-all-authorised-presentations_en.pdf
document_name: nutropinaq-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8379675
conversion_datetime: 2025-12-20 07:42:51.646476
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical form    | Route of administration   | Packaging         | Content   | Package size   |
|-----------------|-----------------|------------|------------------------|---------------------------|-------------------|-----------|----------------|
| EU/1/00/164/003 | NutropinAq      | 10 mg/2 ml | Solution for injection | Subcutaneous use          | cartridge (glass) | 2 ml      | 1 cartridge    |
| EU/1/00/164/004 | NutropinAq      | 10 mg/2 ml | Solution for injection | Subcutaneous use          | cartridge (glass) | 2 ml      | 3 cartridges   |
| EU/1/00/164/005 | NutropinAq      | 10 mg/2 ml | Solution for injection | Subcutaneous use          | cartridge (glass) | 2 ml      | 6 cartridges   |